From Motley Fool today. Morgans has been like an jilted ex-lover. Absolute clowns.Paradigm Biopharmaceuticals Ltd (ASX: PAR)
The Paradigm share price is down 6% to $2.38. The catalyst for this appears to be a broker note out of Morgans this morning. According to the note, the broker has downgraded the biopharmaceutical company’s shares to a reduce rating with a $1.68 price target. Morgans made the move on valuation grounds. Though, it also sees downside risk if Paradigm made changes to its US trial to gain FDA approval.
research reports and media, page-2149
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.05M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.5¢ | $191.4K | 900.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 134470 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 42339 | 4 |
View Market Depth
| Last trade - 14.26pm 14/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |